Literature DB >> 18804150

The stop null mice model for schizophrenia displays [corrected] cognitive and social deficits partly alleviated by neuroleptics.

M Bégou1, J Volle, J-B Bertrand, P Brun, D Job, A Schweitzer, M Saoud, T D'Amato, A Andrieux, M-F Suaud-Chagny.   

Abstract

Recently evidence has accumulated that schizophrenia can arise from primary synaptic defects involving structural proteins particularly, microtubule associated proteins. Previous experiments have demonstrated that a STOP (stable tubule only peptide) gene deletion in mice leads to a phenotype mimicking some aspects of positive symptoms classically observed in schizophrenic patients. In the current study, we determined if STOP null mice demonstrate behavioral abnormalities related to the social and cognitive impairments of schizophrenia. Compared with wild-type mice, STOP null mice exhibited deficits in the non-aggressive component of social recognition, short term working memory and social and spatial learning. As described in humans, learning deficits in STOP null mice were poorly sensitive to long term treatment with typical neuroleptics. Since social and cognitive dysfunction have consistently been considered as central features of schizophrenia, we propose that STOP null mice may provide a useful model to understand the neurobiological correlates of social and cognitive defects in schizophrenia and to develop treatments that better target these symptoms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18804150     DOI: 10.1016/j.neuroscience.2008.07.080

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  17 in total

1.  Nitric oxide synthase mediates the ability of darbepoetin alpha to improve the cognitive performance of STOP null mice.

Authors:  Kosuke Kajitani; Michael Thorne; Michel Samson; George S Robertson
Journal:  Neuropsychopharmacology       Date:  2010-03-24       Impact factor: 7.853

2.  Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia.

Authors:  Colm M P O'Tuathaigh; Brian P Kirby; Paula M Moran; John L Waddington
Journal:  Schizophr Bull       Date:  2009-11-24       Impact factor: 9.306

3.  Eclalbasaponin II Ameliorates the Cognitive Impairment Induced by Cholinergic Blockade in Mice.

Authors:  Won Yong Jung; Haneul Kim; Se Jin Jeon; Hye Jin Park; Hyuck Jai Choi; Nam Jae Kim; Dong Hyun Kim; Dae Sik Jang; Jong Hoon Ryu
Journal:  Neurochem Res       Date:  2017-11-21       Impact factor: 3.996

4.  Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice.

Authors:  Antonio Ortega-Alvaro; Auxiliadora Aracil-Fernández; María S García-Gutiérrez; Francisco Navarrete; Jorge Manzanares
Journal:  Neuropsychopharmacology       Date:  2011-03-23       Impact factor: 7.853

Review 5.  Effects of antipsychotic D2 antagonists on long-term potentiation in animals and implications for human studies.

Authors:  Rae Price; Bahar Salavati; Ariel Graff-Guerrero; Daniel M Blumberger; Benoit H Mulsant; Zafiris J Daskalakis; Tarek K Rajji
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-05-10       Impact factor: 5.067

6.  New horizons in schizophrenia treatment: autophagy protection is coupled with behavioral improvements in a mouse model of schizophrenia.

Authors:  Avia Merenlender-Wagner; Zeev Shemer; Olga Touloumi; Roza Lagoudaki; Eliezer Giladi; Annie Andrieux; Nikolaos C Grigoriadis; Illana Gozes
Journal:  Autophagy       Date:  2014       Impact factor: 16.016

7.  Chronic administration of atypical antipsychotics improves behavioral and synaptic defects of STOP null mice.

Authors:  David Delotterie; Geoffrey Ruiz; Jacques Brocard; Annie Schweitzer; Corinne Roucard; Yann Roche; Marie-Françoise Suaud-Chagny; Karine Bressand; Annie Andrieux
Journal:  Psychopharmacology (Berl)       Date:  2009-11-21       Impact factor: 4.530

8.  Disruptions of Sleep/Wake Patterns in the Stable Tubule Only Polypeptide (STOP) Null Mouse Model of Schizophrenia.

Authors:  Maxine F Profitt; Samuel Deurveilher; George S Robertson; Benjamin Rusak; Kazue Semba
Journal:  Schizophr Bull       Date:  2016-03-02       Impact factor: 9.306

9.  Altered circadian activity and sleep/wake rhythms in the stable tubule only polypeptide (STOP) null mouse model of schizophrenia.

Authors:  Samuel Deurveilher; Kristin Robin Ko; Brock St C Saumure; George S Robertson; Benjamin Rusak; Kazue Semba
Journal:  Sleep       Date:  2021-04-09       Impact factor: 5.849

Review 10.  The microtubule cytoskeleton at the synapse.

Authors:  Julie Parato; Francesca Bartolini
Journal:  Neurosci Lett       Date:  2021-03-26       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.